PFAS can enter an industrial site as a processing aid, coating component, surfactant, impurity, or part of a supplied mixture, then leave through wastewater without appearing in the final product specification. That makes PFAS wastewater supplier declarations a procurement control: downstream biosolids questions may begin with information requested before the chemical is approved.
The declaration should sit inside a reliable chemical compliance file with product identity, supplier correspondence, change notices, wastewater assumptions, and review dates. It should not be mistaken for an SDS, a Certificate of Analysis, or proof that every discharge requirement has been satisfied.
Biosolids Risk Begins Upstream of the Treatment Plant
EPA released draft guidance on July 1, 2026, addressing potential risk-reduction practices for PFOA and PFOS in sewage sludge and biosolids. The guidance is voluntary, remains in draft form, and is open for public comment through September 4, 2026. It is directed primarily to wastewater treatment facilities, landowners, farmers, agencies, and the public rather than creating a new supplier-declaration mandate.
The draft biosolids guidance nevertheless sharpens the upstream procurement question. EPA identifies industrial facilities among the sources from which wastewater treatment plants may receive PFAS, and the draft discusses source reduction and pretreatment as approaches used by states and utilities.
Its land-application recommendations also show why discharge composition can affect decisions far beyond the sewer connection. The draft discusses avoiding areas near fishable or drinking-water waters, locations accessible to young children, and agricultural uses with higher human-exposure potential.
A buyer approving a chemical may therefore influence a later decision about treatment, sludge management, testing, land application, or disposal. Wastewater is part of product approval, even when the purchased material performs exactly as expected in production.
Broad PFAS Claims Can Hide the Real Documentation Gap
Procurement teams often receive short statements such as “PFAS-free,” “no added PFAS,” or “compliant with current requirements.” These phrases may sound decisive, but their value depends entirely on the definition, product scope, evidence source, and jurisdiction behind them.
A declaration can also become misleading when it applies to a product family rather than the exact material being purchased. Different grades, manufacturing sites, raw-material sources, additives, or packaging systems may not share the same PFAS profile.
Timing matters as well. A declaration prepared before a formulation change, supplier substitution, revised PFAS definition, or new testing program may no longer support the current purchase. Undated statements create weak evidence because buyers cannot tell which product version was reviewed.
The first procurement task is therefore not to accept or reject the claim. It is to define exactly what the supplier is declaring, which evidence supports it, and which parts of the product or supply chain remain outside the statement.
PFAS Wastewater Supplier Declarations Need a Narrow Scope
A useful declaration should identify the exact product, supplier legal entity, formulation or grade, date, and the PFAS definition used. “PFAS-free” is weak when it does not explain whether the statement covers intentionally added substances, known impurities, process aids, packaging contact, or only a limited analytical result.
The statement should also distinguish knowledge from testing. A supplier may state that no PFAS is intentionally added based on formulation records. That does not prove that none is present at any concentration. A laboratory report may show that listed analytes were not detected above stated reporting limits, but it does not establish the absence of unmeasured PFAS.
Procurement should ask whether the declaration applies to the product as supplied, the manufacturing process, or both. It should identify excluded components and explain whether upstream raw-material suppliers were included in the review.
The aim is defined evidence, not absolutes. EHS and wastewater specialists can then decide whether the evidence is sufficient for the site’s permit, pretreatment obligations, sampling plan, customer requirements, and risk profile.
SDS, CoA, TDS, and Declarations Prove Different Things
An SDS communicates hazard and safe-use information for a product. It is not designed to provide a complete inventory of every nonhazardous component or a comprehensive PFAS determination.
A Certificate of Analysis reports batch-specific test results against stated parameters. Unless PFAS testing is included with a method, analyte list, result, and reporting limit, the CoA says nothing specific about PFAS. A Certificate of Conformance confirms that a batch or shipment meets defined requirements, but its value depends on those requirements.
A Technical Data Sheet describes performance properties and recommended applications. It may support process evaluation but does not establish wastewater composition or regulatory status. A regulatory declaration addresses a defined compliance question and should state its scope, assumptions, jurisdiction, and validity date.
These documents should be compared rather than substituted for one another. Document names are not evidence scopes.
Wastewater Questions Belong in Material Approval
The approval team can convert a broad concern into a defined document request.
| Approval question | Appropriate evidence | What it does not prove |
|---|---|---|
| Is PFAS intentionally added? | Signed formulation-based supplier declaration | Absence of impurities or contamination |
| Were specific PFAS measured? | Laboratory report with method and reporting limits | Absence of unmeasured PFAS |
| Does the batch meet purchase requirements? | CoA or CoC tied to the specification | Wastewater acceptability unless specified |
| How may the material enter wastewater? | Site process and mass-flow review | Supplier-wide regulatory compliance |
| Has the product changed? | Supplier change-control notice | That earlier discharge assumptions remain valid |
The table separates supplier evidence from site conclusions. A supplier can describe the material, but the industrial user must evaluate its own process, wastewater pathways, and applicable federal, state, and local requirements.
Procurement Changes Can Alter the Discharge Profile
A substitute may match viscosity, purity, pH, or performance while changing fluorinated content or wastewater behavior. New suppliers, alternate manufacturing sites, modified formulations, larger purchase volumes, and cleaning-process changes should reopen the review.
Industrial users are responsible for applicable pretreatment requirements and may need self-monitoring, reporting, notifications, and records. The industrial-user compliance framework also operates alongside state, local, permit, and control-authority requirements, which may differ by facility.
Purchase specifications can require a current declaration and advance notice of relevant changes. They should not impose undefined claims that suppliers cannot substantiate. Where testing is required, the parties should agree on analytes, method, laboratory qualifications, sample basis, units, and reporting limits.
Records should connect the approved product to the process line, expected annual usage, wastewater destination, sampling data, and control-authority communications. That connection makes a supplier declaration actionable rather than decorative.
The Next Land-Use Question Starts at the Purchase Order
EPA’s 2026 draft does not convert every industrial purchase into a new legal reporting duty, and it should not be presented that way. It does show how PFOA and PFOS entering a wastewater system can shape later decisions about pretreatment, biosolids management, and land use.
Strong PFAS wastewater supplier declarations give procurement and EHS teams a defined starting point: exact product identity, stated scope, evidence basis, exclusions, date, and change notification. The purchasing decision then carries enough information for the site to evaluate wastewater consequences before they become a treatment-plant or land-management problem.
FAQ’s
Is a PFAS-free statement enough for wastewater approval?
Usually not by itself. The statement should define PFAS, identify the exact product and formulation, explain whether it covers intentional use or analytical testing, list exclusions, and state its date and evidence basis.
Does an SDS disclose every PFAS in a mixture?
Not necessarily. SDS composition disclosure follows hazard-communication requirements and may not list every component. A separate supplier declaration or targeted analytical report may be needed for the site’s wastewater review.
When should a PFAS wastewater declaration be renewed?
Renew it after formulation, supplier, manufacturing-site, raw-material, packaging, process, or regulatory changes, and on a defined review cycle. Site sampling or new control-authority requirements may also trigger reassessment.